🔴 Nuvation Bio is trading 4.06% down today with no clear company-specific catalyst

Nuvation Bio is trading 4.06% down now at $6.03, with no clear company-specific catalyst emerging on September 11, 2026.

• Conference commentary on IBTROZI, safusidenib, and the DDC platform occurred September 9–10, not during this session.
• The move extends weakness from $6.28 on September 10 and $6.52 on September 9.
• Despite a sharply higher broader market, the decline appears disconnected; reliable coverage has not identified a direct trigger, keeping confidence low.